10 Nov 2016
Neoadjuvant endocrine therapy - designed to reduce the size of breast tumours before surgical removal - appears to be as effective as neoadjuvant chemotherapy for patients with localized, oestrogen-receptor (ER)-positive breast cancer with considerably fewer side effects. The study was published in JAMA Oncology.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024